4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-26-037830
Director sold 5,682 shares at an average $515.44 ($2,928,716)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −40 | $506.68 | $20,267 | 27,657 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −320 | $508.24 | $162,637 | 27,337 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −151 | $510.36 | $77,064 | 27,186 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −610 | $511.40 | $311,952 | 26,576 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −439 | $512.50 | $224,988 | 26,137 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −40 | $512.97 | $20,519 | 26,097 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −343 | $514.67 | $176,532 | 25,754 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −657 | $515.92 | $338,961 | 25,097 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −723 | $516.87 | $373,694 | 24,374 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −1,497 | $517.59 | $774,835 | 22,877 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −782 | $518.76 | $405,669 | 22,095 | D |
| Levy Richard S Director | 2026-05-22 | Sale 10b5-1 | −80 | $519.98 | $41,598 | 22,015 | D |
| Open-market sales · 5,682 sh · avg $515.44 · $2,928,716 | |||||||
Loading xslF345X06/wk-form4_1779487311.xml…